Kris Van Den Bogaert

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Cell-free DNA fragmentome analysis informs pregnancy outcome in patients with immune-mediated disease.

Cell-free DNA fragmentome analysis informs pregnancy outcome in patients with immune-mediated disease.

Journal: Science translational medicine

Published: August 19, 2026

Copy Number Variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders - the DDD-Africa study.

Copy Number Variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders - the DDD-Africa study.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Copy Number Variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders - the DDD-Africa study.

Copy Number Variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders - the DDD-Africa study.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Copy number variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders-the DDD-Africa study.

Copy number variant analysis by exome sequencing is an effective approach to optimize diagnostic yield for developmental disorders-the DDD-Africa study.

Journal: European journal of human genetics : EJHG

Published: January 21, 2026

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12 -Related Developmental Disorders.

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12 -Related Developmental Disorders.

Journal: American journal of medical genetics. Part A

Published: January 16, 2026

Copy-Number Profiling and Methylation-Based Tumor Typing during Prenatal Cell-Free DNA Screening.

Copy-Number Profiling and Methylation-Based Tumor Typing during Prenatal Cell-Free DNA Screening.

Journal: Clinical chemistry

Published: July 10, 2025

Advancing Genotype-Phenotype Analysis through 3D Facial Morphometry: Insights from Cri-du-Chat Syndrome.

Advancing Genotype-Phenotype Analysis through 3D Facial Morphometry: Insights from Cri-du-Chat Syndrome.

Journal: medRxiv : the preprint server for health sciences

Published: June 10, 2025

Advancing genotype-phenotype analysis through 3D facial morphometry: insights from Cri-du-Chat syndrome.

Advancing genotype-phenotype analysis through 3D facial morphometry: insights from Cri-du-Chat syndrome.

Journal: Journal of medical genetics

Published: May 20, 2025

MINDDS-connect: a federated data platform integrating biobanks for meta cohort building and analysis.

MINDDS-connect: a federated data platform integrating biobanks for meta cohort building and analysis.

Journal: European journal of human genetics : EJHG

Published: February 07, 2025

Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort Study.

Persistent Uninterpretable or Failed Prenatal Cell-Free DNA Screening Indicates a High-Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA-Analysis: A Prospective Cohort Study.

Journal: Prenatal diagnosis

Published: January 07, 2025

Chromosomal analysis and short-term outcome of prenatally diagnosed congenital heart disease.

Chromosomal analysis and short-term outcome of prenatally diagnosed congenital heart disease.

Journal: Scientific reports

Published: September 05, 2024

Rare Autosomal Trisomies and Adverse Perinatal Outcomes.

Rare Autosomal Trisomies and Adverse Perinatal Outcomes.

Journal: The New England journal of medicine

Published: July 10, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026